Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 0185-0022

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0185-0022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure depicting two molecular formulas, likely representing orphenadrine citrate. The left structure includes a benzene ring and a nitrogen atom, while the right structure shows a citrate molecule with three carboxylic acid groups. The molecular formula C18H23NO · C6H8O7 and molecular weight 461.51 are indicated.*

FDA Label Image

Image 02

Orphenadrine Citrate Extended-Release Tablets, USP 100 mg label from Sandoz Inc. The label states the product is for oral use and prescription only, containing 100 extended-release tablets. It includes storage instructions, dosage guidance, and child-resistant packaging information. The label displays the NDC 0185-0022-01 and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.